Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.

Dand N, Duckworth M, Baudry D, Russell A, Curtis CJ, Lee SH, Evans I, Mason KJ, Alsharqi A, Becher G, Burden AD, Goodwin RG, McKenna K, Murphy R, Perera GK, Rotarescu R, Wahie S, Wright A, Reynolds NJ, Warren RB, Griffiths CEM, Smith CH, Simpson MA, Barker JN; BADBIR Study Group; BSTOP Study Group; PSORT Consortium.

J Allergy Clin Immunol. 2019 Jun;143(6):2120-2130. doi: 10.1016/j.jaci.2018.11.038. Epub 2018 Dec 20.

PMID:
30578879
2.

Pillars article: A lymphotoxin-B-specific receptor. Science. 1994. 264: 707-710.

Crowe PD, Vanarsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA.

J Immunol. 2014 Mar 1;192(5):2015-8. No abstract available.

3.

Allergic contact dermatitis to peppermint foot spray.

Kalavala M, Hughes TM, Goodwin RG, Anstey AV, Stone NM.

Contact Dermatitis. 2007 Jul;57(1):57-8. No abstract available.

PMID:
17577363
4.

Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells.

Goodwin RG, Kell WJ, Laidler P, Long CC, Whatley SD, McKinley M, Badminton MN, Burnett AK, Williams GT, Elder GH.

Blood. 2006 Jan 1;107(1):60-2. Epub 2005 Sep 8.

5.

Use of complementary medicine among outpatients with dermatologic conditions within Yorkshire and South Wales, United Kingdom.

Baron SE, Goodwin RG, Nicolau N, Blackford S, Goulden V.

J Am Acad Dermatol. 2005 Apr;52(4):589-94.

PMID:
15793507
6.

Variations in registration of skin cancer in the United Kingdom.

Goodwin RG, Holme SA, Roberts DL.

Clin Exp Dermatol. 2004 May;29(3):328-30.

PMID:
15115532
7.

The TRAIL of Death.

Goodwin RG, Smith CA.

Apoptosis. 1998 Mar;3(2):83-8.

PMID:
14646505
9.

Vitiligo following narrow-band TL-01 phototherapy for psoriasis.

Goodwin RG, Finlay AY, Anstey AV.

Br J Dermatol. 2001 Jun;144(6):1264-6. No abstract available.

PMID:
11422056
10.

Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.

Cerutti A, Schaffer A, Goodwin RG, Shah S, Zan H, Ely S, Casali P.

J Immunol. 2000 Jul 15;165(2):786-94.

11.

CDw137.

Goodwin RG.

J Biol Regul Homeost Agents. 2000 Apr-Jun;14(2):139-41. No abstract available.

PMID:
10841291
12.

Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48.

Kubin MZ, Parshley DL, Din W, Waugh JY, Davis-Smith T, Smith CA, Macduff BM, Armitage RJ, Chin W, Cassiano L, Borges L, Petersen M, Trinchieri G, Goodwin RG.

Eur J Immunol. 1999 Nov;29(11):3466-77.

13.

IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.

Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D, Wiley SR.

J Immunol. 1999 Jul 15;163(2):920-6.

14.

Functional analysis of TRAIL receptors using monoclonal antibodies.

Griffith TS, Rauch CT, Smolak PJ, Waugh JY, Boiani N, Lynch DH, Smith CA, Goodwin RG, Kubin MZ.

J Immunol. 1999 Mar 1;162(5):2597-605.

15.

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH.

Nat Med. 1999 Feb;5(2):157-63.

PMID:
9930862
16.

Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung.

Boussaud V, Soler P, Moreau J, Goodwin RG, Hance AJ.

Eur Respir J. 1998 Oct;12(4):926-31.

17.
18.

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.

Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG.

Immunity. 1997 Dec;7(6):813-20.

19.

Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors.

Smith CA, Smith TD, Smolak PJ, Friend D, Hagen H, Gerhart M, Park L, Pickup DJ, Torrance D, Mohler K, Schooley K, Goodwin RG.

Virology. 1997 Sep 29;236(2):316-27.

20.

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.

Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA.

J Exp Med. 1997 Oct 6;186(7):1165-70.

21.

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT.

EMBO J. 1997 Sep 1;16(17):5386-97.

22.

Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.

Degli-Esposti MA, Davis-Smith T, Din WS, Smolak PJ, Goodwin RG, Smith CA.

J Immunol. 1997 Feb 15;158(4):1756-62.

PMID:
9029113
23.

Reverse signaling via CD30 ligand.

Wiley SR, Goodwin RG, Smith CA.

J Immunol. 1996 Oct 15;157(8):3635-9.

PMID:
8871664
24.

Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha.

Smith CA, Hu FQ, Smith TD, Richards CL, Smolak P, Goodwin RG, Pickup DJ.

Virology. 1996 Sep 1;223(1):132-47.

25.

CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.

Gruss HJ, Pinto A, Gloghini A, Wehnes E, Wright B, Boiani N, Aldinucci D, Gattei V, Zagonel V, Smith CA, Kadin ME, von Schilling C, Goodwin RG, Herrmann F, Carbone A.

Am J Pathol. 1996 Aug;149(2):469-81.

26.

CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.

Wendtner CM, Schmitt B, Gruss HJ, Druker BJ, Emmerich B, Goodwin RG, Hallek M.

Cancer Res. 1995 Sep 15;55(18):4157-61.

27.

Regulation of murine B cell growth and differentiation by CD30 ligand.

Shanebeck KD, Maliszewski CR, Kennedy MK, Picha KS, Smith CA, Goodwin RG, Grabstein KH.

Eur J Immunol. 1995 Aug;25(8):2147-53.

PMID:
7664777
28.

Fas ligand mediates activation-induced cell death in human T lymphocytes.

Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH.

J Exp Med. 1995 Jan 1;181(1):71-7.

29.

Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.

Gruss HJ, DaSilva N, Hu ZB, Uphoff CC, Goodwin RG, Drexler HG.

Leukemia. 1994 Dec;8(12):2083-94.

PMID:
7528856
30.

B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors.

Benjamin D, Sharma V, Knobloch TJ, Armitage RJ, Dayton MA, Goodwin RG.

J Immunol. 1994 May 15;152(10):4749-57.

PMID:
8176200
31.

A lymphotoxin-beta-specific receptor.

Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA.

Science. 1994 Apr 29;264(5159):707-10.

PMID:
8171323
32.

Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.

Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG.

Blood. 1994 Apr 15;83(8):2045-56.

33.

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

Smith CA, Farrah T, Goodwin RG.

Cell. 1994 Mar 25;76(6):959-62. Review. No abstract available.

PMID:
8137429
34.

Characterization of the human CD27 ligand, a novel member of the TNF gene family.

Hintzen RQ, Lens SM, Beckmann MP, Goodwin RG, Lynch D, van Lier RA.

J Immunol. 1994 Feb 15;152(4):1762-73.

PMID:
8120385
35.
36.

Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor.

Goodwin RG, Din WS, Davis-Smith T, Anderson DM, Gimpel SD, Sato TA, Maliszewski CR, Brannan CI, Copeland NG, Jenkins NA, et al.

Eur J Immunol. 1993 Oct;23(10):2631-41.

PMID:
8405064
37.

Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.

Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB.

J Immunol. 1993 Aug 1;151(3):1548-61.

PMID:
8393046
38.

Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

Goodwin RG, Alderson MR, Smith CA, Armitage RJ, VandenBos T, Jerzy R, Tough TW, Schoenborn MA, Davis-Smith T, Hennen K, et al.

Cell. 1993 May 7;73(3):447-56.

PMID:
8387892
39.

Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.

Howard OM, Clouse KA, Smith C, Goodwin RG, Farrar WL.

Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2335-9.

40.

The interleukin-7 receptor gene is at 5p13.

Lynch M, Baker E, Park LS, Sutherland GR, Goodwin RG.

Hum Genet. 1992 Jul;89(5):566-8.

PMID:
1634235
41.

Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells.

Ware CF, Crowe PD, Vanarsdale TL, Andrews JL, Grayson MH, Jerzy R, Smith CA, Goodwin RG.

J Immunol. 1991 Dec 15;147(12):4229-38.

PMID:
1661312
42.

Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor.

Goodwin RG, Anderson D, Jerzy R, Davis T, Brannan CI, Copeland NG, Jenkins NA, Smith CA.

Mol Cell Biol. 1991 Jun;11(6):3020-6.

43.

T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor.

Smith CA, Davis T, Wignall JM, Din WS, Farrah T, Upton C, McFadden G, Goodwin RG.

Biochem Biophys Res Commun. 1991 Apr 15;176(1):335-42.

PMID:
1850261
44.

Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine.

Overell RW, Clark L, Lynch D, Jerzy R, Schmierer A, Weisser KE, Namen AE, Goodwin RG.

Mol Cell Biol. 1991 Mar;11(3):1590-7.

45.

A new cytokine receptor superfamily.

Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ.

Trends Biochem Sci. 1990 Jul;15(7):265-70. Review.

PMID:
2166365
46.

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.

Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG.

Science. 1990 May 25;248(4958):1019-23.

PMID:
2160731
47.

Characterization of the human and murine IL-7 genes.

Lupton SD, Gimpel S, Jerzy R, Brunton LL, Hjerrild KA, Cosman D, Goodwin RG.

J Immunol. 1990 May 1;144(9):3592-601.

PMID:
2329282
48.

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily.

Goodwin RG, Friend D, Ziegler SF, Jerzy R, Falk BA, Gimpel S, Cosman D, Dower SK, March CJ, Namen AE, et al.

Cell. 1990 Mar 23;60(6):941-51.

PMID:
2317865
49.

Interleukin-7: a new hematopoietic growth factor.

Namen AE, Williams DE, Goodwin RG.

Prog Clin Biol Res. 1990;338:65-73. Review.

PMID:
2189141
50.

Lymphopoiesis and IL-7.

Widmer MB, Morrissey PJ, Goodwin RG, Grabstein KH, Park LS, Watson JD, Kincade PW, Conlon PJ, Namen AE.

Int J Cell Cloning. 1990 Jan;8 Suppl 1:168-70; discussion 171-2. Review.

PMID:
2182735

Supplemental Content

Loading ...
Support Center